Trial Site Detail

 

Drug:
HER-2 B Cell Peptide
Trial:
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Ohio State University Comprehensive Cancer Center

     
Columbus , OH 43210
USA

 

Principal Investigator:
 Pravin T.P Kaumaya, PhD
Contact:
 Pravin Kaumaya, PhD 614-292-7028 Pravin.Kaumaya@osumc.edu Tanios Bekaii-Saab, MD 614-293-9863 Tanios.Bekaii-saab@osumc.edu
Activation Status of this Site:
 Closed
Notes about this Site:
Ohio State University Comprehensive Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.